Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 1
2004 12
2005 16
2006 16
2007 8
2008 20
2009 16
2010 9
2011 30
2012 23
2013 16
2014 15
2015 16
2016 12
2017 9
2018 19
2019 18
2020 17
2021 25
2022 30
2023 26
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

334 results

Results by year

Filters applied: . Clear all
Page 1
Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis.
Grönberg C, Rattik S, Tran-Manh C, Zhou X, Rius Rigau A, Li YN, Györfi AH, Dickel N, Kunz M, Kreuter A, Matei EA, Zhu H, Skoog P, Liberg D, Distler JH, Trinh-Minh T. Grönberg C, et al. Among authors: kreuter a. Ann Rheum Dis. 2024 Apr 9:ard-2023-225158. doi: 10.1136/ard-2023-225158. Online ahead of print. Ann Rheum Dis. 2024. PMID: 38594058
S2k‐Leitlinie: Diagnostik und Therapie der zirkumskripten Sklerodermie.
Kreuter A, Moinzadeh P, Kinberger M, Horneff G, Worm M, Werner RN, Hammacher A, Krieg T, Wenzel J, Oeschger M, Weibel L, Müllegger R, Hunzelmann N. Kreuter A, et al. J Dtsch Dermatol Ges. 2024 Apr;22(4):605-621. doi: 10.1111/ddg.15328_g. J Dtsch Dermatol Ges. 2024. PMID: 38574014 German.
Attenuation of fibroblast activation and fibrosis by adropin in systemic sclerosis.
Liang M, Dickel N, Györfi AH, SafakTümerdem B, Li YN, Rigau AR, Liang C, Hong X, Shen L, Matei AE, Trinh-Minh T, Tran-Manh C, Zhou X, Zehender A, Kreuter A, Zou H, Schett G, Kunz M, Distler JHW. Liang M, et al. Among authors: kreuter a. Sci Transl Med. 2024 Mar 27;16(740):eadd6570. doi: 10.1126/scitranslmed.add6570. Epub 2024 Mar 27. Sci Transl Med. 2024. PMID: 38536934
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema.
Knobler R, Geroldinger-Simić M, Kreuter A, Hunzelmann N, Moinzadeh P, Rongioletti F, Denton C, Mouthon L, Cutolo M, Smith V, Gabrielli A, Bagot M, Olesen AB, Foeldvari I, Jalili A, Kähäri VM, Kárpáti S, Kofoed K, Olszewska M, Panelius J, Quaglino P, Seneschal J, Sticherling M, Sunderkötter C, Tanew A, Wolf P, Worm M, Skrok A, Rudnicka L, Krieg T. Knobler R, et al. Among authors: kreuter a. J Eur Acad Dermatol Venereol. 2024 Mar 8. doi: 10.1111/jdv.19937. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38456518
Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics.
Rius Rigau A, Li YN, Matei AE, Györfi AH, Bruch PM, Koziel S, Devakumar V, Gabrielli A, Kreuter A, Wang J, Dietrich S, Schett G, Distler JHW, Liang M. Rius Rigau A, et al. Among authors: kreuter a. Circ Res. 2024 Mar 29;134(7):875-891. doi: 10.1161/CIRCRESAHA.123.323299. Epub 2024 Mar 5. Circ Res. 2024. PMID: 38440901
S2k guideline: Diagnosis and therapy of localized scleroderma.
Kreuter A, Moinzadeh P, Kinberger M, Horneff G, Worm M, Werner RN, Hammacher A, Krieg T, Wenzel J, Oeschger M, Weibel L, Müllegger R, Hunzelmann N. Kreuter A, et al. J Dtsch Dermatol Ges. 2024 Apr;22(4):605-620. doi: 10.1111/ddg.15328. Epub 2024 Mar 1. J Dtsch Dermatol Ges. 2024. PMID: 38426689
44-jähriger Patient mit Veränderungen aller Nägel.
Wehry UP, Matull J, Kreuter A. Wehry UP, et al. Among authors: kreuter a. Dtsch Med Wochenschr. 2024 Mar;149(6):331-332. doi: 10.1055/a-2249-1347. Epub 2024 Feb 27. Dtsch Med Wochenschr. 2024. PMID: 38412991 German. No abstract available.
334 results